Pertussis - HAN
Pertussis (Whooping Cough)
Pertussis is a highly contagious respiratory disease caused by the bacteria Bordetella pertussis. Pertussis lives in the nose, mouth, and throat of infected individuals. The bacteria are shed in nasopharyngeal secretions and can be spread through coughing, sneezing, or direct contact with fluids from the nose, mouth, or throat of an infected person. If untreated, infected individuals can spread the pertussis bacteria to others from 1 week before cough onset to 21 days after cough onset. Untreated infants (<1 year) remain infectious for up to 42 days from cough onset. When treated with antibiotics, the infectious period is reduced to 5 days after the initiation of treatment. Severe infections can result in complications such as pneumonia among all age groups. Seizures and encephalopathy generally occur only among infants. The average incubation period for pertussis is 7-10 days with a range of 4-21 days.
Case Definition
A cough illness lasting ≥2 weeks with at least 1 of the following signs or symptoms:
- Paroxysms of coughing, OR
- Inspiratory “whoop,” OR
- Post-tussive vomiting, OR
- Apnea (with or without cyanosis) (for infants <1 year of age only)
- Locally available FDA approved PCR tests for B. pertussis
- Multiplex assay: Biofire FilmArray Respiratory Panel, bioMérieux
- Targets the pertussis toxin promoter (ptxP): highly specific
- Multiplex assay: Biofire FilmArray Respiratory Panel, bioMérieux
- Other locally available PCR tests for B. Pertussis
- Singleplex assay: Typically an in-house laboratory developed PCR method
- Targets the insertion sequence IS481: highly sensitive
- It is important to note research has found that PCR can detect pertussis in infants less than 6 months of age up to 3 weeks following pertussis treatment initiation. Pertussis positive PCR results may correspond to the presence of antibiotic-damaged bacteria. As a result, the clinical significance of pertussis detected by PCR after initiation of antibiotic treatment is unclear. For more information, see Real-Time PCR Measurement of Persistence of Bordetella pertussis DNA.
Bordetella pertussis Commerical Lab Reference Table
Collect nasopharyngeal (NP) swabs as soon as pertussis is suspected, within 21 days of cough onset.
- Carefully insert swab through the nares straight back (not upwards) until reaching the posterior wall of the nasopharynx.
- Gently roll and rub the swab.
- Leave the swab in place for several seconds before slowly removing the swab.
- For Specimen Handling, see CDC Specimen Collection Guidelines.
IMPORTANT 2019 PROVIDER COMMUNICATION
UPDATE: Increased Pertussis Activity November 20, 2019
Increased Pertussis Activity in North Side Chicago Childcare Settings February 27, 2019
2019 CDPH Algorithm for Pertussis Exposure in Childcare Settings
***Consider reporting suspect pertussis cases in our NEW Online Case Report Form so we can exchange information in a confidential format more quickly (supported by IDPH portal REDCap survey). See more reporting instructions to the below.
It is recommended pregnant women receive the tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine during each pregnancy. To maximize the maternal antibody response and passive antibody transfer to the infant, pregnant women should receive the vaccine between 27 through 36 weeks gestation. For more information, see Pregnancy and Whooping Cough.
Cases should be reported within 24 hours.
Complete the Online Case Report Form (*preferred)
or Fax paper Case Report Form to: (312) 746-6388
or Call Provider Reporting Hotline: (312) 743-9000
Sign up for electronic reporting through the
Illinois National Electronic DIsease & Sureillance System (I-NEDSS)
For questions during non-business hours call 311. (312-744-5000 if outside the City of Chicago.)
CDC: Manual for the Surveillance of Vaccine-Preventable Diseases; Chapter 10: Pertussis
CDC’s Pertussis Vaccination Website
CDPH HAN Alert Pertussis Clinical Guidelines for Testing and Treatment of Persons with Pertussis
CDC: Pertussis Specimen Collection
Clinical Guidelines for Management of Healthcare Personnel Exposed to Pertussis